Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management.
Journal: Alcohol and alcoholism (Oxford, Oxfordshire)
Published: February 26, 2026
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: January 17, 2026
Rates and Factors Associated With Hepatocellular Carcinoma Diagnosis, Stage, Treatment, and Survival.
Journal: Gastro hep advances
Published: September 29, 2025
COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area Veterans.
Journal: Gastro hep advances
Published: May 05, 2025
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: September 12, 2024
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis.
Journal: Alcohol, clinical & experimental research
Published: September 04, 2024
Portal Vein Thrombosis After Transarterial Embolization for Hepatocellular Carcinoma.
Journal: JAMA surgery
Published: December 27, 2023
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis.
Journal: Hepatology communications
Published: November 30, 2023
Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States.
Journal: The American journal of medicine
Published: October 31, 2023
Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era.
Journal: Gastro hep advances
Published: October 04, 2023
Hepatocellular carcinoma after direct-acting antivirals for hepatitis C is associated with KIR-HLA types predicting weak NK cell-mediated immunity.
Journal: European journal of immunology
Published: July 22, 2023
Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
Journal: Digestive diseases and sciences
Published: May 01, 2023
Last Updated: 09/26/2026